We investigated the relationship between HSP27 phosphorylation and collagen-stimulated activation of platelets in patients with diabetes mellitus (DM). Platelet-rich plasma was prepared from blood of type 2 DM patients. The platelet aggregation was analyzed in size of aggregates by an aggregometer using a laser scattering method. The protein phosphorylation was analyzed by Western blotting. Phosphorylated-HSP27 and PDGF-AB released from platelets were measured by ELISA. The phosphorylated-HSP27 levels at Ser-78 and Ser-82 induced by collagen were directly proportional to the platelet aggregation. Total HSP27 levels in platelets were decreased concomitantly with the phosphorylation. The released HSP27 levels were significantly correlated with the phosphorylated levels of HSP27 in the platelets stimulated by 0.3 μg/ml collagen. The low dose collagen-stimulated release of HSP27 was detected but relatively small in healthy donors. The released levels of PDGF-AB were in parallel with the levels of released HSP27. Area under the curve (AUC) of small aggregation (9-25 μm) induced by 0.3 μg/ml collagen was inversely proportional to the levels of released HSP27. AUC of large aggregation (50-70 μm) was directly proportional to the levels of released HSP27. Exogenous recombinant phosphorylated- HSP27 hardly affected the aggregation or the released levels of PDGF-AB induced by collagen. These results strongly suggest that HSP27 is released from human platelets accompanied with its phosphorylation induced by collagen, which is correlated with the acceleration of platelet aggregation in type 2 DM patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457785PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128977PLOS

Publication Analysis

Top Keywords

released hsp27
16
platelet aggregation
12
induced collagen
12
levels released
12
hsp27
11
levels
9
platelets accompanied
8
type patients
8
released
8
directly proportional
8

Similar Publications

Background: Heat shock protein-27 is the microprotein released from renal parenchyma during diabetic oxidative stress, while microalbumin is the plasma protein that appears in urine in diabetic nephropathy.

Methods: This case-control study was conducted from Jan to Sep 2021 in the Physiology department, BMC, BMCH, Quetta. The current study included 105 patients with an age range from 30-50 years and was divided into three groups: i) a control group of healthy participants, ii) a diabetic risk group: participants without signs of diabetic nephropathy and diabetic duration from 1-5 years, iii) diabetic nephropathy group: participants having >30 mg/dl of v microalbumin in urine and diabetic duration from 5-10 years.

View Article and Find Full Text PDF

The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease.

Theranostics

September 2024

Department of Anatomy and Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.

Article Synopsis
  • Ferroptosis is linked to the loss of dopaminergic neurons in Parkinson's disease (PD), with Hspb1 levels being elevated in patients' brains, but its exact role is not fully understood.
  • Researchers used dopaminergic neurons from human iPSCs and a compound called Coniferaldehyde (CFA) to study how Hspb1 and Nrf2 interact and their impact on neuroprotection in PD.
  • The study found that Nrf2 can activate Hspb1, crucial for the protective effect of CFA; however, excessive Hspb1 ultimately leads to neuronal death and inflammation, revealing a complex role in PD that needs further exploration for potential therapies.
View Article and Find Full Text PDF

Cardiovascular disease is one of the leading causes of mortality worldwide, primarily driven by atherosclerosis, a chronic inflammatory condition contributing significantly to fatalities. Various biological determinants affecting cardiovascular health across different age and sex groups have been identified. In this context, recent attention has focused on the potential therapeutic and preventive role of increasing circulating levels of heat shock protein 27 (plasma HSP27) in combating atherosclerosis.

View Article and Find Full Text PDF

RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies.

Bioorg Chem

September 2024

Department of Inorganic and Organic Chemistry, Organic Chemistry Section, Institute of Biomedicine, University of Barcelona (IBUB), Barcelona, Spain. Electronic address:

Combined therapies play a key role in the fight against complex pathologies, such as cancer and related drug-resistance issues. This is particularly relevant in targeted therapies where inhibition of the drug target can be overcome by cross-activating complementary pathways. Unfortunately, the drug combinations approved to date -mostly based on small molecules- face several problems such as toxicity effects, which limit their clinical use.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on the role of Lens Epithelium-Derived Growth Factor (LEDGF) in maintaining cell health and how its dysregulation due to aging and oxidative stress leads to gene silencing and cellular damage.
  • - Researchers found that specific methylation patterns around the LEDGF gene's promoter reduced LEDGF levels, leading to increased reactive oxygen species (ROS) and associated problems in aging human lens epithelial cells.
  • - The use of a demethylating agent, 5-Aza deoxycytidine, helped restore LEDGF expression by reversing the methylation changes, suggesting potential therapeutic strategies to combat cellular damage related to LEDGF repression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!